WWMSC
CTIC

Wagner Wealth Management (South Carolina)’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Wagner Wealth Management (South Carolina)’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-16
Closed – – 710
2017
Q4 		$0 Buy
+16
New +$47 ﹤0.01% 814

Other funds holding CTIC

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wagner Wealth Management (South Carolina)'s CTIC Position: Q1 2018 in Review

Wagner Wealth Management (South Carolina) sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q1 2018, closing a stake of 16 shares.

Wagner Wealth Management (South Carolina) first reported a position in CTIC in Q4 2017 and held it in 1 quarter. The position peaked at $0 in Q4 2017. 67 funds tracked by Wall St. Rank hold CTIC as of Q1 2018.

  • Wagner Wealth Management (South Carolina) reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q1 2018 after selling out during the quarter.
  • Wagner Wealth Management (South Carolina) sold 16 CTI BioPharma Corp. (DE) Common Stock shares in Q1 2018.
  • Wagner Wealth Management (South Carolina) first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q4 2017 and held it in 1 quarter.
  • Wagner Wealth Management (South Carolina)'s CTI BioPharma Corp. (DE) Common Stock position peaked at $0 in Q4 2017.
  • 67 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q1 2018.

Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q1 2018, filed 10 May 2018.